Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with
fully integrated commercial and drug development operations with a
primary focus in hematology and oncology, today announced key
presentations of clinical and scientific data at the 55th Annual Meeting
of the American Society of Hematology (ASH), being held ... read more
Mart®, a community franchise of more than 3,000
independently owned pharmacies across all 50 states, announced today
that it will offer its member pharmacies access to EQuIPP™, an online
information management platform that makes pharmacy performance data
available to ... read more
AsiaInfo-Linkage, Inc. (NASDAQ: ASIA) ("AsiaInfo-Linkage" or the "Company"), a leading provider of telecommunication software solutions and services in China, today announced that it has received clearance from the Ministry of Commerce of the People's Republic of China pursuant to the Anti-Monopoly Law of the People's Republic of China with respect to the merger (the "Merger") contemplated by the previously announced Agreement and Plan of Merger (the "Merger Agreement"), dated May 12, 2013, by and among the Company, Skipper Limited ("Parent") ... read more
Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to report that it has appointed Enkhmart (Michelle) Dudleenamjil, MD, Ph.D., to the position of Supply Chain Manager.
"Michelle brings a wealth of knowledge and nutraceutical industry experience to Nutranomics, including a Ph.D. from Brigham Young University in microbiology and several published scientific papers related to inter-cellular transport," stated Nutranomics CEO, Dr. Tracy K. Gibbs. "I am confident that her superior technical expertise, and strong product development and ... read more
A new white paper from the Tuberous Sclerosis Alliance (TS Alliance), entitled "Vigabatrin-Associated Visual Field Loss (VAVFL): What You Need to Know," was released today at the American Epilepsy Society annual meeting in Washington, DC. The white paper was written by Darcy A. Krueger, MD, PhD, Associate Professor, Clinical Pediatrics and Neurology, Tuberous Sclerosis Clinic, Cincinnati Children's Hospital. Vigabatrin is approved in the United States by the Food and Drug Administration to treat infantile spasms and medically refractory complex ... read more
On the heels of a record Black Friday Weekend and Cyber Monday, Walmart.com is offering customers another chance to shop the hottest and most surprising deals from Black Friday weekend with a one-day only "Green Monday" cyber event on Dec. 9.
Green Monday refers to the second Monday of December, which is becoming a leading traffic and sales day for online shopping. According to comScore, Green Monday was the third-highest online shopping day of the 2012 holiday shopping season. Green ... read more
Global Experience Specialists (GES), a leading global provider of exhibition, event, and entertainment experiences, announced that it has hired Paul Wedesky as senior vice president of audio visual services. Wedesky has more than 25 years of multimedia experience in the trade show and meetings industry. Most recently he was Senior Vice President of National Operations for PSAV and had been Senior Vice President of PSAV's Sales, Convention & Tradeshow Division.
"Clients have told us that they want ... read more
RAVPower Q4 2013 sales are boosting thanks to the recent success of the RP-WD01 FileHub on Amazon.com. The RAVPower FileHub allows users to create their own wireless networks and transfer files between media devices, such as SD cards, USB flash drives, and external hard drives.
As with all RAVPower products, the goal was to create a product that was both simple and convenient to use. "We feel that it is our duty to create products that people can't leave home without. ... read more
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased ARIAD Pharmaceuticals, Inc. ("ARIAD" or the "Company") (NASDAQ GS: ARIA) stock between December 12, 2011 and October 8, 2013. The Complaint alleges that throughout the Class Period defendants made false and misleading statements regarding the safety and efficacy of the leukemia drug Iclusig.
For more information, click here: http://zlk.9nl.com/ariad-pharmaceuticals-aria.
On October ... read more
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Oppenheimer 24th Annual Healthcare Conference in New York City on December 11, 2013 at 8:20 AM ET/5:20 AM PT.
A live webcast and subsequent archived replay of the presentation will be accessible at http://ir.questcor.com/events.cfm. The replay will be available for approximately 90 days after the event.
About Questcor ... read more
Today, the Asbestos
Disease Awareness Organization (ADAO), released the mobile app on
the subject of asbestos. ADAO is a non-profit organization dedicated to
preventing asbestos-related diseases through education, advocacy and
The ADAO ... read more
With the arrival of the holiday season, beginning in October, people all over the United States tend to start putting on unwanted pounds. In fact some studies have shown that most of the weight gained over the course of a year by Americans occurs in the last three months of the year.
This makes perfect sense because if you think about you start with October and Halloween, where many children and parents consume chocolaty treats that they normally would not. ... read more
Global Experience Specialists (GES), a leading global provider of exhibition, event, and entertainment experiences, announced enhancements to Expresso, its premier online management tool for exhibitors, and GES Connect, a fully integrated, online planning tool for event organizers. Expresso combines the art of a customized show experience with the science of exhibitor surveys and usage data. It is designed to offer everything exhibitors need in one place, on any device, accessed with one password. GES is continuously introducing new features based ... read more
Nodality, Inc., an innovative biotechnology company advancing discovery,
development and use of transformative therapies by revealing functional
systems biology, announced today that Laura Brege, President and Chief
Executive Officer of Nodality, will present a corporate overview at the
Oppenheimer 24th Annual Healthcare Conference on Wednesday,
... read more
KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a composition of matter patent covering certain antibodies targeting EphA3, including KaloBios' experimental anti-cancer monoclonal antibody (mAb), KB004. The allowed claims relate to high-affinity Humaneered(®) antibodies to the EphA3 receptor.
Geoffrey Yarranton, Ph.D., KaloBios' Chief Scientific Officer and co-inventor, commented, "EphA3 is a tyrosine kinase receptor that is expressed on hematologic cancers and solid tumors, including tumor stem ... read more
Overstock.com, Inc. (NASDAQ: OSTK) today applauded the bipartisan passage of the Innovation Act, a measure targeting abusive litigation practices in the patent area.
The company singled out Chairman Bob Goodlatte, R-Va., of the House Judiciary Committee, and Congressman Jason Chaffetz, R-Utah, an original co-sponsor and early champion of the reforms aimed at curbing the litigation tactics of patent trolls. Patent trolls are entities which assert flimsy infringement actions to extort settlements because of high defense costs.
"Overstock.com has been at the ... read more
A discovery by a research team led by Dr. Ryohei Yasuda at the Max
Planck Florida Institute for Neuroscience has significantly advanced
basic understanding of biochemical mechanisms associated with how
memories are formed.
The surprising results of the team's ... read more
American Pacific Corporation (NASDAQ: APFC) ("AMPAC") announced today that it will release its Fiscal 2013 year-end and fourth quarter financial results on Thursday, December 12, 2013, immediately after the stock market closes. Joseph Carleone, Chairman and Chief Executive Officer and Dana Kelley, Vice President, Chief Financial Officer and Treasurer, will host a related investor teleconference/webcast at 1:30 p.m. Pacific Standard Time.
Callers may listen to the live presentation, which will be followed by a question and answer session, by dialing ... read more
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Oppenheimer 24(th) Annual Conference to be held December 10-11, 2013 at the Crown Plaza in New York. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 9:30 a.m. ET on Wednesday, December 11, 2013.
(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )
The presentation will also be webcast on the "For Investors" section of the Auxilium website under ... read more
Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that it has
submitted a Prior Approval Supplement (PAS) with the U.S. Food and Drug
Administration (FDA) for an additional bulk manufacturing suite for EXPAREL®
(bupivacaine liposome injectable suspension). Under the reauthorization
of the ... read more